Research programme: macrolide antibacterials - Macrolide Pharmaceuticals

Drug Profile

Research programme: macrolide antibacterials - Macrolide Pharmaceuticals

Alternative Names: Antibacterials - Macrolide Pharmaceuticals; Antibiotics - Macrolide Pharmaceuticals; Macrolide antibiotics - Macrolide Pharmaceuticals

Latest Information Update: 26 Mar 2015

Price : $50

At a glance

  • Originator Macrolide Pharmaceuticals
  • Class Macrolides; Small molecules
  • Mechanism of Action Protein 50S ribosomal subunit inhibitors; Protein synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Research Bacterial infections

Most Recent Events

  • 04 Mar 2015 Early research in Bacterial infections in USA (PO)
  • 04 Mar 2015 Early research in Bacterial infections in USA (IV)
  • 04 Mar 2015 Macrolide Pharmaceuticals in-licenses synthesis technology from Harvard's Office of Technology Development
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top